Press releases | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Press releases

PRESS RELEASE

published on 02/05/2026 at 11:16, 7 months 7 days ago

FUCHS strengthens its presence in Türkiye with the complete takeover of the joint venture OPET FUCHS
FUCHS strengthens its presence in Türkiye with the complete takeover of the joint venture OPET FUCHS, enhancing market position in the industrial, OEM, mining, and automotive aftermarket sectors. Transaction expected to be completed by April 2026

Acquisition Market Position Takeover Türkiye FUCHS
PRESS RELEASE

published on 02/05/2026 at 11:00, 7 months 7 days ago

CHANGES TO THE BOARD OF DIRECTORS
Grit Real Estate Income Group announces changes to the Board of Directors, with the resignation of Mr. Gareth Schnehage and appointment of Mr. Hugo Jordaan as the new Chief Financial Officer and Executive Director

Board Of Directors Resignation Appointment Financial Officer GRIT
PRESS RELEASE

published on 02/05/2026 at 10:48, 7 months 7 days ago

EQS-Adhoc: Evonik Industries AG: Executive Board adjusts dividend policy
Evonik Industries AG adjusts dividend policy to range between 40-60% of adjusted net income to enhance financial flexibility. Initial dividend of €1.00 per share proposed for FY 2025. Preliminary adjusted EBITDA around €1.874 billion

EBITDA Dividend Policy Financial Flexibility Evonik Industries Adjusted Net Income
PRESS RELEASE

published on 02/05/2026 at 10:05, 7 months 7 days ago

VT Markets Powers Reliable Gold Trading Amid Extreme Market Volatility
VT Markets demonstrates strong gold trading performance amidst high market volatility, with stable execution and increased client engagement

Market Volatility Gold Trading Client Engagement Trading Platform VT Markets
PRESS RELEASE

published on 02/05/2026 at 10:05, 7 months 7 days ago

Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese
Frontier Rare Earths Limited announces strategic technology supply agreement with Carester, US$20m investment, and DFS commencement for Zandkopsdrift project in South Africa

Frontier Rare Earths Limited Carester Technology Supply Agreement US$20 Million Investment DFS Commencement
PRESS RELEASE

published on 02/05/2026 at 10:00, 7 months 7 days ago

Information mensuelle relative au nombre total de droit de vote Janvier 2026
HF COMPANY communique sur le nombre total d'actions et de droits de vote au 31/01/2026

Droits De Vote Capital Social Actions AMF HF Company
PRESS RELEASE

published on 02/05/2026 at 09:05, 7 months 7 days ago

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
BioNxt Solutions Inc. announced signing a letter of intent for exclusive rights to advanced drug chaperone technology, enhancing its oral dissolvable thin-film platform

BioNxt Solutions Inc. Letter Of Intent Drug Chaperone Technology Oral Dissolvable Thin-film Biotechnology Developer
PRESS RELEASE

published on 02/05/2026 at 09:00, 7 months 7 days ago

Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Research update from NuWays AG on Eckert & Ziegler SE highlights positive sales performance and market potential in therapeutic isotopes. Analysis projects strong growth outlook. Read more: eckert-and-ziegler-se-2026-02-05-update-en-70c5a

NuWays AG Growth Outlook Market Potential Eckert & Ziegler SE Therapeutic Isotopes
PRESS RELEASE

published on 02/05/2026 at 09:00, 7 months 7 days ago

Original-Research: Limes Schlosskliniken AG (von NuWays AG): BUY
NuWays AG releases research report on Limes Schlosskliniken AG, highlighting strong FY25 performance and profitability increase. Target price raised to EUR 710

NuWays AG Target Price Limes Schlosskliniken AG Profitability Increase Research Report
PRESS RELEASE

published on 02/05/2026 at 09:00, 7 months 7 days ago

Original-Research: Semperit AG Holding (von NuWays AG): BUY
Analysis of Semperit AG Holding by NuWays AG reveals steady performance in Q4 2025 and FY25, with expectations of growth in FY26. Company's prospects strong, maintaining BUY rating at €18.5

Investment NuWays AG Financial Analysis Growth Prospects Semperit AG Holding

Accesswire

Published on 09/12/2026 at 02:35, 9 hours 16 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 12 hours 51 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 13 hours 46 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 14 hours 26 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 18 hours 51 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 4 hours 20 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 13 hours 36 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 13 hours 40 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 16 hours 6 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 17 hours 35 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 4 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 4 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 4 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 4 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 16 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE